Despite advancements in the cloning of the human genome, biomedical innovations at patient level are rare events. Translational medicine is, however, a burgeoning science that shows potential to reverse the trend. This textbook provides a survey of translational medicine, emphasising its emerging scientific backbone, its strengths and weaknesses. It explores all aspects of preclinical and clinical issues relevant to the success of translational pharmaceutical or medical device or diagnostic innovations, including target risk assessment, biomarker evaluation, and predictivity grading for both efficacy and toxicity; early human trial designs, adequate to guide stop or go decisions on the grounds of biomarker panels; and biostatistical methods to analyze multiple readout situations and quantify risk projections. Translational Science in Medicine provides guidance to design profiling strategies for new approaches to the field. By generating dialogue about translational science Wehling explores the implications of this field on the future of patient care.
A state-of-the-art survey of translational medicine, emphasising its emerging scientific backbone, its strengths, and weaknesses. This textbook explores all aspects of preclinical and clinical issues relevant to the success of translational pharmaceutical or medical device or diagnostic innovations guiding readers in designing profiling strategies for new approaches to the field.
Publisher
Cambridge University Press
Publication Date
Jun 2010
ISBN
9780521888691
Pages
404 p.
Item Type
Book
Format
Hardcover
Unavailable
This product is currently out of stock. Please check back later.
Recently Viewed Items
Related Products
Your cart is full
You can add up to 100 items to your cart. To add more items, please remove some first.